Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.
about
Homocysteine lowering interventions for preventing cardiovascular eventsHomocysteine lowering interventions for preventing cardiovascular eventsElevated plasma homocysteine is positively associated with age independent of C677T mutation of the methylenetetrahydrofolate reductase gene in selected Egyptian subjectsThe J-shape association of ethanol intake with total homocysteine concentrations: the ATTICA studyThe effect on endothelial function of vitamin C during methionine induced hyperhomocysteinaemiaHomocysteine and ischaemic stroke in men: the Caerphilly studyHomocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow upAmerican College of Medical Genetics consensus statement on factor V Leiden mutation testingHomocysteine: a new cardiac risk factor?Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups: datPlasma vitamin B(6) and risk of myocardial infarction in women.Homocysteine.Synergy of circulating miR-212 with markers for cardiovascular risks to enhance estimation of atherosclerosis presence.Total homocysteine and cardiovascular disease.Survival bias and drug interaction can attenuate cross-sectional case-control comparisons of genes with health outcomes. An example of the kinesin-like protein 6 (KIF6) Trp719Arg polymorphism and coronary heart disease.Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease.Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.Blood levels of homocysteine and atherosclerotic vascular disease.Diagnosis and treatment of hyperhomocysteinemia.Homocysteine, vitamins, and coronary artery disease. Comprehensive review of the literatureCoronary heart disease prevention: nutrients, foods, and dietary patterns.Association between B vitamins supplementation and risk of cardiovascular outcomes: a cumulative meta-analysis of randomized controlled trials.Polymorphisms of methylenetetrahydrofolate reductase gene as the genetic predispositions of coronary artery diseases in eastern India.Dietary intake of vitamin B-6, plasma pyridoxal 5'-phosphate, and homocysteine in Puerto Rican adults.Folate and vitamin B-12 and risk of fatal cardiovascular disease: cohort study from Busselton, Western Australia.Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.Folate in colorectal cancer, prostate cancer and cardiovascular disease.Blood spot-based measures of glucose homeostasis and diabetes prevalence in a nationally representative population of young US adultsEffects of a carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease.Homocysteine and occlusive arterial disease.Homocyst(e)ine and coronary heart disease: pharmacoeconomic support for interventions to lower hyperhomocyst(e)inaemia.Too much folate: a risk factor for cancer and cardiovascular disease?Herbal, vitamin, and mineral supplement use in patients enrolled in a cardiac rehabilitation program.New paradigms in preventive cardiology: unconventional coronary risk factorsEndothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia.Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approachHomocysteine and atherothrombosis: diagnosis and treatment.Interaction of folate intake and the paraoxonase Q192R polymorphism with risk of incident coronary heart disease and ischemic stroke: the atherosclerosis risk in communities studyMethylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate.
P2860
Q24239981-D4F62095-7F90-4581-9B68-376152A0CF44Q24244823-BFAAEEAC-B5C8-4136-BDB0-7C184FCDAB51Q24791309-8DF9FBB6-80E1-4DD4-8B2C-D87E3C39B8E2Q24792786-A04810DF-CB5C-4609-ADE6-64C292F629DEQ24800878-A5729F08-9EDD-4950-9562-12C122753B7AQ28345707-FB0F88DF-06D8-469A-98E1-AA65576FDFEAQ28345971-7B1F7409-E9EB-49C1-8010-314B50DC0E66Q28361651-A905977A-60DE-484F-A02A-281B71890669Q31982199-D76B1504-04DD-4B7B-AFD6-8D2E6DD97EF2Q33424203-4F995C76-1B9C-4FD3-BE43-A18E0C05032EQ33707261-10DB2510-9E00-4AB5-8A12-691F4BB0B86CQ33732664-0E4C4BA2-0AA7-49B5-A486-20836581C8A6Q33739176-05881918-E66D-45ED-BAD0-9EFBAA8418DAQ33785883-991635ED-CCC6-4168-884B-BECFC468D0AEQ33854825-01C98B81-1EFB-4711-8E3B-6B6DBF9B9741Q33915599-F6FAE04A-8217-4ECF-9C4D-86BA2D584FE1Q33955167-F3699F49-C4BF-4418-950B-178CE86FB51CQ34038098-EBF92DDE-0F40-478B-B7E3-653C26A45DA7Q34107404-515C181D-721B-407A-88C9-5D16E7AE3A7FQ34109461-693413F2-D32E-4E3F-964C-4DD000D2468BQ34121446-762BCF4B-8D32-49DD-AC29-4DFF3E8496A5Q34185229-8188E135-0791-4351-905E-59116935A1F3Q34215572-92789832-1F7F-4738-BD14-79A9056C172CQ34313930-F5750E95-D8EC-4A4E-8876-2C502819F924Q34340964-AE4B899B-685B-4F9B-916E-7656C23A7779Q34445357-793C1D47-6613-4CE6-8584-A0B276FC3CE8Q34577250-49243A1E-118D-45A6-89CC-7E56B2F2EE61Q34582313-2AF9D5DC-6C0C-4173-8F69-45EC493CEA9DQ34630281-51EE750F-3DF5-41EE-8A89-ADBED9B46C16Q34691265-4198DB06-5430-4CCA-A255-7A0344EC1879Q34703668-E4250848-0162-4A73-B2C3-C46E12913FD5Q34716812-6DECF8F1-B369-4E5E-AA9E-59F81E3D965DQ34895640-411F5D18-4FE1-4345-B788-0BAFA89ADA3EQ35050124-38465825-A803-498E-A1E8-6CAF180680BEQ35052188-A65CA497-551C-4D2C-B5D7-B219FEBCDC68Q35055199-84C0356A-F857-4617-954A-DAA4783E24CDQ35062755-A3EC285E-3AE7-43B0-9819-0B94F1C01F88Q35148387-75A2A426-AD4D-4C47-B769-044D45AEAB15Q35302760-2C60E4D1-4208-497D-8865-3C759C68F822Q35371861-3AAF5047-94F7-420A-96CD-B9E04CB25A58
P2860
Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Prospective study of coronary ...... k in Communities (ARIC) study.
@en
Prospective study of coronary ...... k in Communities (ARIC) study.
@nl
type
label
Prospective study of coronary ...... k in Communities (ARIC) study.
@en
Prospective study of coronary ...... k in Communities (ARIC) study.
@nl
prefLabel
Prospective study of coronary ...... k in Communities (ARIC) study.
@en
Prospective study of coronary ...... k in Communities (ARIC) study.
@nl
P2093
P356
P1433
P1476
Prospective study of coronary ...... k in Communities (ARIC) study.
@en
P2093
Eckfeldt JH
Malinow MR
McGovern PG
P304
P356
10.1161/01.CIR.98.3.204
P407
P577
1998-07-01T00:00:00Z